Point-of-Care Coagulation Testing Devices Market is Expanding at a CAGR of ~6% Between 2019 and 2027

Point-of-Care Coagulation Testing Devices Market: Introduction

Transparency Market Research delivers key insights on the global point-of-care coagulation testing devices market. In terms of revenue, the global point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the point-of-care coagulation testing devices market report.

Report Overview @

https://www.transparencymarketresearch.com/point-of-care-coagulation-testing-market.html

According to TMR's analysis of the global point-of-care coagulation testing devices market, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level of convenience and test modes. Moreover, these players focus on increasing their penetration in new regions through mergers and acquisitions, thereby increasing their share in the global point-of-care coagulation testing devices market. For instance, in April 2019, Ortho Clinical Diagnostics, in collaboration with Diazyme Laboratories, Inc. launched its D-Dimer assay, the latest offering in Ortho's MicroTip Partnership Assay (MPA) program.

In terms of method, the PT/INR segment held the largest share of the global point-of-care coagulation testing devices market in terms of revenue in 2018. The segment is anticipated to dominate the market from 2019 to 2027. The ever-increasing trend of point-of-care testing and self-monitoring with PT tests is expected to fuel the growth of the segment. Furthermore, the high reliability of coagulation status on PT testing is one of the factors likely to boost the growth of the segment during the forecast period.

Request PDF Sample of Point-of-Care Coagulation Testing Devices Market Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56190

Based on product, the technological leap from conventional testing to automation and use of lower blood volumes contribute to the growth of the instruments/analyzers segment. Increase in the demand for quicker results, rise in the trend of self- and home-monitoring, surge in POC testing, and reliable results are the major factors projected to drive the segment in the global point-of-care coagulation testing devices market.

Global Point-of-Care Coagulation Testing Devices Market: Prominent Regions

North America accounted for a leading share of the global point-of-care coagulation testing devices market in terms of revenue in 2018, followed by Europe There has been a gradual rise in the demand for multiplexing diagnostic tools, and an increase in investments toward the development of these tools. Surge in the demand for more rapid and specific diagnosis to support rapid decision-making drives the global point-of-care coagulation testing devices market.

Additionally, the demand for these tools in physician offices and emergency departments as standard testing tools is rising. Recent FDA approvals for point-of-care coagulation testing devices, such as Abbott's i-STAT, indicate the increasing demand and support among both, public and private sectors, along with manufacturers' focus on addressing this rising demand. Asia Pacific is witnessing gradual adoption of novel products, increase in healthcare expenditure, and change in dynamics in the in vitro diagnostics industry. These factors are leading to a rise in the adoption of new technologies among hospitals and diagnostic laboratories.

For More Details, Request A PDF Brochure Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56190

Key manufacturers in the global point-of-care coagulation testing devices market focus on collaborations in order to sustain in this competitive market space. Increase in the sales of point-of-care coagulation testing devices through e-Commerce sites and purchase of devices online have positively impacted the global point-of-care coagulation testing devices market. Easy-to-compare prices of numerous products has led to a rise in the preference for online sales.

Global Point-of-Care Coagulation Testing Devices Market: Key Players

Key players operating in the global point-of-care coagulation testing devices market include F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers, Medtronic plc, Haemonetics Corporation, HemoSonics, LLC, Micropoint Bioscience, Inc., Werfen, Sienco, Inc., and Koninklijke Philips N.V.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.